Architecture of a Coat for the Nuclear Pore Membrane by Hsia, Kuo-Chiang et al.
1 
Cell, Volume 131 
Supplemental Data 
Architecture of a Coat for 
the Nuclear Pore Membrane 




























  Crystal 6 
K2PtCl4 
Data collection           
Synchrotron ALS ALS  NSLS NSLS NSLS ALS ALS ALS ALS ALS 
Beamline BL8.2.2 BL8.2.1 X29 X29 X29 BL8.2.2 BL8.2.1 BL8.2.1 BL8.2.1 BL8.2.1 
Space group C2221 C2221 C2221 C2221 C2221 C2221 C2221 C2221 C2221 C2221 
Cell dimensions             






























   α, β, γ  (°) α=β=γ=90° α=β=γ=90° α=β=γ=90° α=β=γ=90° α=β=γ=90° α=β=γ=90° α=β=γ=90° α=β=γ=90° α=β=γ=90° α=β=γ=90° 


















Wavelength 1.00000 1.25490 0.97900 0.97930 0.95000 1.00910 1.14010 1.14050 1.10700 1.07210 
Resolution (Å) 20.0-3.0 50.0-4.0 30.0-3.4 30.0-3.65 30.0-3.80 50.0-3.9 50.0-3.80 50.0-3.95 50.0-4.45 50.0-4.7 
Rsym (%)
b 11.0 (64.6) 11.2 (55.2) 13.6 (66.4) 14.6 (72.3) 14.5 (69.2) 8.8 (60.1) 10.4 (47.7) 12.1 (65.5) 10.8 (82.8) 9.8 (79.4) 
<I / σI> b 19.3 (1.7) 11.6 (2.2) 9.0 (1.7) 8.6 (1.7) 7.5 (1.8) 12.5 (2.3) 11.8 (2.9) 10.2 (2.0) 10.3 (1.7) 13.3 (1.3) 
Completeness (%)b 97.3 (92.4) 96.7 (97.7) 99.1 (99.1) 98.8 (99.0) 95.2 (93.1) 91.8 (90.2) 99.4 (96.6) 99.4 (97.8) 99.4 (97.9) 94.8 (86.8) 
Redundancy 11.2 3.1 3.3 3.2 2.8 3.2 3.7 3.7 3.7 5.0 
           
Refinement           




4,327 (8 %) 
         
Rwork / Rfree (%) 24.7 / 28.9          
No. atoms 22,618          
R.m.s deviations           
   Bond lengths (Å) 0.009          
   Bond angles (°) 1.6          
aEMTS, ethylmercurithiosalicylate 
bHighest-resolution shell is shown in parentheses. 
 
Table S2.  Crystallographic Analysis of the Monoclinic Crystals 
 





  Crystal 3 
K2OsO4 
 Crystal 4 
EMTS
a 
 Crystal 5 
SeMet 
Data collection          
Synchrotron ALS  ALS ALS ALS NSLS NSLS ALS ALS ALS 
Beamline BL8.2.2 BL8.2.1 BL8.2.1 BL8.2.1 X29 X29 BL8.2.1 BL8.2.1 BL8.2.2 
Space group C2 C2 C2 C2 C2 C2 C2 C2 C2 
Cell dimensions            





























































Wavelength 1.00000 1.25480 1.25490 0.91980 1.14000 1.14040 1.00910 1.00930 0.97950 
Resolution (Å) 20.0-3.15 20.0-5.0 50.0-5.0 20.0-6.5 20.0-3.75 20.0-3.75 20.0-3.60 20.0-4.0 50.0-4.0 
Rsym (%)
b 14.5 (74.6) 8.2 (40.9) 7.6 (42.8) 9.1 (49.8) 14.2 (83.4) 11.6 (59.2) 9.9 (90.7) 6.6 (31.1) 7.5 (31.6) 
<I / σI>
b 17.9 (1.9) 10.4 (1.8) 9.8 (1.8) 10.6 (1.6) 9.6 (1.4) 12.2 (1.4) 8.0 (2.1) 12.1 (2.0) 10.6 (2.2) 
Completeness (%)
b 95.7 (77.7) 96.5 (96.2) 96.8 (93.7) 98.1 (96.1) 98.7 (93.4) 97.5 (89.4) 97.3 (89.7) 97.1 (89.5) 80.2 (49.5) 
Redundancy 10.8 1.9 1.9 1.9 3.5 3.4 1.8 1.7 1.8 
          
Refinement          





        
Rwork / Rfree 24.7 / 29.2         
No. atoms 22,566         
R.m.s deviations          
   Bond lengths (Å) 0.009         
   Bond angles (°) 1.6         
aEMTS, ethylmercurithiosalicylate 
bHighest-resolution shell is shown in parentheses. 
 
Table S3.  Expression Constructs 
 
Protein Species Residues Expression 
vector 
Restriction 
sites 5’, 3’ 
N-terminal sequence overhang 
Nup145C yeast 1-711 pETDuet-1 BamHI, NotI MGSSHHHHHHSGDP 
      
Nup145C yeast 125-555 pETDuet-1 BamHI, NotI MGSSHHHHHHSGDP 
      
Nup96 human 1112-1169 pGEX-6P1 BamHI, XhoI GPLGGGGG 
      
Sec13 yeast 1-297 pET24b NdeI, XhoI untagged 
      
Sec13 human 1-322 pET24b NdeI, XhoI untagged 
      
Sec13 human 1-316 pET24b NdeI, XhoI untagged 
      
Sec13 human 1-322 pET28a-pp NdeI, XhoI GPHM 











SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Protein Expression and Purification 
A DNA fragment containing residues 1112-1169 of H. sapiens Nup96 was amplified by 
PCR and cloned into the BamHI and XhoI restriction sites of pGEX-6P1 (GE Heathcare). The 
expression of the Sec13-Nup96DIM complex was carried out in the same manner as the 
expression of the Sec13-Nup145C complex was. However, cells were re-suspended on ice in 
a buffer containing 50 mM TRIS, pH 8.0, 100 mM NaCl, 5 mM DTT, bovine lung aprotinin (20 
µg/ml), 2 mM PMSF, and Complete EDTA-free Protease inhibitor cocktail tablets (Roche). For 
purification, the cells were lysed with a cell disruptor (Avestin), and the lysate was centrifuged 
for 90 minutes at 40,000 g. The resulting supernatant fraction was filtered through a 0.45 µm 
filter (Nalgene) and loaded onto a glutathione Sepharose 4B column (GE Healthcare) that was 
equilibrated in buffer A (50 mM TRIS, pH 8.0, 100 mM NaCl, 5 mM DTT). The resin was first 
washed in buffer A, and the bound protein was eluted, using a gradient of buffer B (buffer A 
supplemented with 20 mM glutathione). The eluted protein fractions were pooled, extensively 
dialyzed against buffer A, and cleaved with GST-PreScission protease for 36 hours in order to 
remove the N-terminal GST-tag. Protease cleavage left an additional five residues on the N-
terminus with sequence GPLGS. The sample was then loaded onto a glutathione Sepharose 
4B column to remove any uncleaved protein, free GST, and GST-PreScission. After 
concentration, the samples were injected onto a Superdex 75 16/60 column that was 
equilibrated in buffer C (20 mM TRIS, pH 8.0, 100 mM NaCl, 5 mM DTT). The protein-
containing fractions were pooled, concentrated to 20 mg/ml, snap-frozen in liquid nitrogen, and 





Blom, N., Gammeltoft, S., and Brunak, S. (1999). Sequence and structure-based prediction of 
eukaryotic protein phosphorylation sites. J. Mol. Biol. 294, 1351-1362. 
Huang, H.D., Lee, T.Y., Tzeng, S.W. & Horng, J.T. (2005). KinasePhos: a web tool for 
identifying protein kinase-specific phosphorylation sites. Nucleic Acids Res. 33, W226-229. 
